We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

T-Cell Tests Unreliable in Establishing Previous COVID-19 Infection, Finds New Study

By LabMedica International staff writers
Posted on 05 Oct 2021
Print article
Illustration
Illustration

T-cell tests can be unreliable in establishing previous COVID-19 infection, according to the findings of a new study.

In the study, scientists at Uppsala University (Uppsala, Sweden) and Karolinska Institutet (Stockholm, Sweden) jointly analyzed if T-cell tests can be used to determine whether people have had COVID-19. By analyzing the T cells’ responses to varying peptide compositions, the researchers were able to see that different peptide pools produced divergent responses, and that a risk of false-positive responses existed. In the scientists’ view, this risk is due to the fact that the peptides can give rise to responses from memory T cells that originated in some way other than through a SARS-CoV-2 infection – from a common cold, for example.

When the scientists attempted to avoid using peptides that might give rise to these cross-reactive responses, there was an increase in the specificity of the test – that is, its ability to establish genuine negative responses – but its sensitivity (ability to detect a true positive response) simultaneously declined at the time of sampling and analysis, which was 4-5 months post COVID-19.

“In the follow-up study, the participants with a relatively mild initial disease clearly didn’t always have measurable SARS-CoV-2 specific T cells in blood. But among those with a disease that’s initially more serious, there were more who had measurable SARS-CoV-2-specific T cells in blood over time,” said Sara Mangsbo, a research scientist in immuno-oncology at Uppsala University. “The correlation we found between the severity of the disease and a measurable, established memory response in the blood isn’t entirely unexpected; but it’s still important to establish, since the use of T-cell tests has been a matter of public discussion for numerous reasons."

“It’s also important to say that the subjects’ blood doesn’t always contain the memory T cells after the disease is over. Still, cells in tissues – which aren’t measurable by means of a blood-based test for T cells – may have a part to play in how ill people get during an infection,” said Charlotte Thålin, a specialist doctor and researcher responsible for the COMMUNITY study at Danderyd Hospital and Karolinska Institutet. “T-cell tests will continue to have an important part to play in research and studies, but probably a smaller one in diagnostics and at individual level for SARS-CoV-2 in particular.”

Related Links:
Uppsala University
Karolinska Institutet

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more